Results 171 to 180 of about 21,216 (279)

Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Zhang Y, Wu W, Yang M, Liu J, Wu H, Chen Y.   +5 more
europepmc   +1 more source

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s [PDF]

, 2016
Sahera Dirajlal‐Fargo, Carlee Moser, Todd T. Brown, Theodoros Kelesidis, Michael P. Dubé, James H. Stein, Judith S. Currier, Grace A. McComsey   +7 more
openalex   +1 more source

Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report. [PDF]

Cureus
Chowdhury AH, Chowdhury D, Jahan I, Woghiren A, Saleh M.   +4 more
europepmc   +1 more source

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]

Int J Mol Sci
Gáspár Z, Lakatos B.
europepmc   +1 more source

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma [PDF]

, 2016
Lee Ratner, Daniel A. Rauch, Haley Abel, Breanna Caruso, Ariela Noy, Stefan K. Barta, Samir Parekh, Juan Carlos Ramos, Richard F. Ambinder, Adrienne A. Phillips, John C. S. Harding, Hicham H. Baydoun, Xiaogang Cheng, Steven Jacobson   +13 more
openalex   +1 more source

Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]

J Exp Pharmacol
Rao AM, Sm F, Somashekara D, Gayam PKR, Rahangdale RR, Patil SS, Hariharapura RC.   +6 more
europepmc   +1 more source

Raltegravir in the management of HIV-infected patients

, 2008
Hans-Juergen Stellbrink
openalex   +2 more sources

Persistent Seronegativity and Absence of Intact Proviruses Despite Prolonged Initial Viremia in Early-Treated Perinatal HIV Infection. [PDF]

Open Forum Infect Dis
Charre C, Buseyne F, Mélard A, Gardiennet E, Mariaggi AA, Montange T, Le Chenadec J, Warszawski J, Blanche S, Avettand-Fenoël V, Frange P.   +10 more
europepmc   +1 more source

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]

, 2013
Alderton, W K, Anderson, Rosaleen, Collingwood, S P, Pryde, D C   +3 more
core   +1 more source

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023. [PDF]

J Virus Erad
Ferrer P, Ramos V, Durán M, Maureira D, Beltrán C, Afani A.   +5 more
europepmc   +1 more source